Correlation Between Aequus Pharmaceuticals and Aion Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aequus Pharmaceuticals and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aequus Pharmaceuticals and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aequus Pharmaceuticals and Aion Therapeutic, you can compare the effects of market volatilities on Aequus Pharmaceuticals and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aequus Pharmaceuticals with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aequus Pharmaceuticals and Aion Therapeutic.

Diversification Opportunities for Aequus Pharmaceuticals and Aion Therapeutic

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aequus and Aion is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Aequus Pharmaceuticals and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Aequus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aequus Pharmaceuticals are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Aequus Pharmaceuticals i.e., Aequus Pharmaceuticals and Aion Therapeutic go up and down completely randomly.

Pair Corralation between Aequus Pharmaceuticals and Aion Therapeutic

Assuming the 90 days horizon Aequus Pharmaceuticals is expected to under-perform the Aion Therapeutic. But the otc stock apears to be less risky and, when comparing its historical volatility, Aequus Pharmaceuticals is 11.92 times less risky than Aion Therapeutic. The otc stock trades about -0.17 of its potential returns per unit of risk. The Aion Therapeutic is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  0.58  in Aion Therapeutic on August 30, 2024 and sell it today you would earn a total of  0.47  from holding Aion Therapeutic or generate 81.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aequus Pharmaceuticals  vs.  Aion Therapeutic

 Performance 
       Timeline  
Aequus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aequus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Aion Therapeutic 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

Aequus Pharmaceuticals and Aion Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aequus Pharmaceuticals and Aion Therapeutic

The main advantage of trading using opposite Aequus Pharmaceuticals and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aequus Pharmaceuticals position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.
The idea behind Aequus Pharmaceuticals and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance